The CNS moving voice program: Implementation of a dual voice and physical exercise program for Parkinson’s disease: An applicability study
Objective: To test the applicability of a rehabilitation program for people with Parkinson´s disease that combines speech and motor exercises (The CNS Moving Voice Program).…Best supportive care or palliative care for late stage Parkinsonian syndromes?
Objective: To ask whether best supportive care might be more suitable for patients with Parkinson's disease (PD) and Parkinsonian syndromes and their family than palliative…The effect of levodopa-carbidopa intestinal gel on activities of daily living: Results from the observational MONOTREAT study in advanced Parkinson’s disease patients
Objective: To assess the tolerability and effect of levodopa-carbidopa intestinal gel (LCIG, designated in the United States as carbidopa-levodopa enteral suspension) on activities of daily…Biseptol a new antiParkinsonian agent?
Objective: To evaluate the possible effect of combined intake of levodopa/carbidopa and trimethoprim/sulfamethoxazole on the duration of ON/OFF periods in a PD patient. Background: Drug…Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease
Objective: To determine the feasibility and value of remote blood pressure (BP) monitoring during a clinical trial of isradipine (a dihydropyridine calcium channel antagonist) in…Effects of subthalamic deep brain stimulation in motor and nonmotor function in Parkinson’s disease patients with parkin mutation
Objective: The aim of our study was to evaluate prospectively the changes in motor, nonmotor symptoms (NMS) and quality of life produced by subthalamic deep…Spinal cord stimulation improves freezing of gait in Parkinson’s disease in chronic implanted stn-dbs patients: A case report
Objective: The aim of our study was to evaluate further the potential role of spinal cord stimulation (SCS) as a treatment for gait disturbances and…Pisa syndrome in Parkinson’s disease effectively treated with subthalmic deep brain stimulation: Case report
Objective: To report the case of a 67-year-old Parkinsonian patient with significant and disabling Pisa syndrome (PS) successfully treated with subthalamic nucleus deep brain stimulation…Recharge frequency is not driven by therapy power usage in patients implanted with rechargeable deep brain stimulation systems
Objective: To explore the relationship between recharge frequency and therapy power usage in patients with rechargeable deep brain stimulation (DBS) devices. Background: Advancements in DBS…Non-motor symptoms in progressive supranuclear palsy
Objective: To explore the clinical correlates of Non-motor symptoms (NMS) in progressive supranuclear palsy (PSP) and their differences from healthy aging and Parkinson's disease (PD).…
- « Previous Page
- 1
- …
- 369
- 370
- 371
- 372
- 373
- …
- 405
- Next Page »